Pityriasis rosea after mRNA COVID-19 vaccination.

Abdullah, Lina; Hasbani, Divina; Kurban, Mazen; Abbas, Ossama

Abdullah, Lina; Hasbani, Divina; Kurban, Mazen; Abbas, Ossama.

Abdullah L; Dermatology Department, American University of Beirut Medical Center, Beirut, Lebanon.
Hasbani D; Dermatology Department, American University of Beirut Medical Center, Beirut, Lebanon.
Kurban M; Dermatology Department, American University of Beirut Medical Center, Beirut, Lebanon.
Abbas O; Dermatology Department, American University of Beirut Medical Center, Beirut, Lebanon.

Int J Dermatol ; 60(9): 1150-1151, 2021 Sep.

Article in English | MEDLINE | ID: covidwho-1263834

Subject(s)

COVID-19 Vaccines; Pityriasis Rosea; Pityriasis; COVID-19; COVID-19 Vaccines/adverse effects; Humans; SARS-CoV-2; Vaccination/adverse effects; Vaccines, Synthetic/adverse effects

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Pityriasis / Pityriasis Rosea / COVID-19 Vaccines Topics: Vaccines Limits: Humans Language: English Journal: Int J Dermatol Year: 2021 Document Type: Article Affiliation country: Ijd.15700

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google